Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON Trial.

Lumryz (sodium oxybate extended release) - Avadel

http://www.ncbi.nlm.nih.gov/pubmed/40111738

Anne Marie Morse; Asim Roy; Jennifer Gudeman; John W Winkelman; Lois Krahn

Mar 20, 2025